Metastatic breast cancer trials in Finland

In Finland 8 Also abroad 610

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Where
Helsinki, Kuopio, Tampere, Vaasa
Age
18 years and over
People
400 worldwide
Run by
Pfizer
See details and how to joinNCT07062965 · EU 2025-520566-22-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Where
Tampere, Turku, Vaasa
Age
18 years and over
People
230 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT05894239 · EU 2022-502046-28-00
Phase 3Taking people
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Where
Helsinki, Tampere, Turku, Vaasa
Age
18 years and over
People
1,180 worldwide
Run by
Celcuity Inc
See details and how to joinNCT06757634 · EU 2024-518933-28-01
Phase 2Not yet taking people in Finland
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
Where
Tampere
People
51 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07679269 · EU 2026-525890-38-00
Phase 3Taking people
Measuring Oncological Value of Exercise and Statin (MOVES)
Where
Tampere
Age
18 years and over
People
240
Run by
Pirkanmaan hyvinvointialue
See details and how to join2024-515109-24-00 · EU 2024-515109-24-00
Phase 4Taking people
IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs – a pragmatic randomized-controlled trial (IMPORTANT trial)
Where
Helsinki
Age
65 years and over
People
495 worldwide
Run by
Region Oerebro Laen
See details and how to join2023-506620-87-00 · EU 2023-506620-87-00
Phase 3Taking people
Measuring Oncological Value of Exercise and Statin
Where
Tampere
Age
18 years to 99 years
People
240
Run by
Tampere University Hospital
See details and how to joinNCT05796973
Phase 3Taking people
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Where
Helsinki
Age
70 years and over
People
495 worldwide
Run by
Region Örebro County
See details and how to joinNCT06044623